X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1136) 1136
Publication (74) 74
Patent (19) 19
Book Review (9) 9
Book Chapter (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (674) 674
female (622) 622
index medicus (422) 422
oncology (386) 386
middle aged (381) 381
adult (343) 343
aged (302) 302
obstetrics & gynecology (254) 254
cancer (207) 207
surgery (197) 197
ovarian cancer (191) 191
carcinoma (153) 153
chemotherapy (139) 139
ovarian neoplasms - pathology (135) 135
aged, 80 and over (121) 121
obstetrics and gynecology (118) 118
treatment outcome (116) 116
prognosis (106) 106
neoplasm staging (102) 102
ovarian neoplasms - drug therapy (102) 102
survival (96) 96
laparoscopy (95) 95
care and treatment (93) 93
research (93) 93
analysis (92) 92
retrospective studies (91) 91
hysterectomy (84) 84
cervical cancer (82) 82
endometrial cancer (82) 82
women (77) 77
antineoplastic combined chemotherapy protocols - therapeutic use (73) 73
hematology, oncology and palliative medicine (71) 71
expression (68) 68
health aspects (68) 68
immunohistochemistry (65) 65
laparoscopy - methods (65) 65
ovarian neoplasms - surgery (62) 62
pregnancy (60) 60
disease-free survival (59) 59
medicine & public health (58) 58
oncology, experimental (57) 57
animals (56) 56
tumors (55) 55
uterine cervical neoplasms - pathology (55) 55
male (54) 54
paclitaxel (54) 54
prospective studies (54) 54
endometrial neoplasms - pathology (53) 53
young adult (51) 51
management (50) 50
follow-up studies (49) 49
laparoscopic surgery (49) 49
cisplatin (48) 48
gynecology (48) 48
ovarian neoplasms - genetics (47) 47
breast-cancer (46) 46
combined modality therapy (46) 46
hysterectomy - methods (46) 46
metastasis (46) 46
apoptosis (45) 45
trial (45) 45
hematology (44) 44
neoadjuvant chemotherapy (44) 44
cell line, tumor (43) 43
survival rate (43) 43
uterine cervical neoplasms - surgery (43) 43
antineoplastic agents - therapeutic use (42) 42
endometrial neoplasms - surgery (42) 42
survival analysis (42) 42
cancer patients (39) 39
lymphatic metastasis (39) 39
time factors (39) 39
ovarian neoplasms - metabolism (37) 37
radiotherapy (37) 37
uterine cervical neoplasms - drug therapy (37) 37
clinical trials (36) 36
diagnosis (36) 36
ovarian neoplasms - mortality (36) 36
paclitaxel - administration & dosage (35) 35
patients (35) 35
breast cancer (34) 34
in-vitro (34) 34
lymph node excision (34) 34
neoadjuvant therapy (34) 34
operative time (34) 34
radiation-therapy (34) 34
radical hysterectomy (34) 34
therapy (34) 34
complications (33) 33
disease progression (32) 32
italy (32) 32
adolescent (31) 31
antineoplastic combined chemotherapy protocols - adverse effects (31) 31
pharmacology & pharmacy (31) 31
quality of life (31) 31
risk factors (31) 31
cells (30) 30
cytoreductive surgery (30) 30
drug resistance, neoplasm (30) 30
feasibility studies (30) 30
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 07/2019, Volume 10, Issue 1, pp. 3196 - 15
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 12/2009, Volume 47, Issue 12, pp. 3895 - 3901
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2017, Volume 216, Issue 6, pp. 592.e1 - 592.e11
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 04/2018, Volume 19, Issue 4, p. 961
BRCA1/2 screening in Hereditary Breast and Ovarian Syndrome (HBOC) is an essential step for effective patients' management. Next-Generation Sequencing (NGS)... 
BRCA1/2 | Data analysis | CNV | NGS | MLPA | HBOC | data analysis | OVARIAN-CANCER PATIENTS | QUANTIFICATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | BREAST | TOOLS
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
International Journal of Women's Health, ISSN 1179-1411, 12/2014, Volume 6, pp. 999 - 1010
In this paper, we review the published evidence about the long-term efficacy of the available human papillomavirus (HPV) vaccines and their safety profile. Two... 
Adverse events | Effectiveness | HPV vaccines | Prevention | Care and treatment | Research | Teenage girls | Health aspects | Papillomavirus infections | Risk factors | Studies | Human papillomavirus | Womens health | Aluminum | Human immunodeficiency virus--HIV | Infections | Vaccines | Deoxyribonucleic acid--DNA | Cervical cancer | Regulatory approval
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 02/2019, Volume 26, Issue 2, pp. 523 - 530
To evaluate morbidity and oncological outcome in a multicentre series of women with gynaecological malignancies infiltrating pelvic side wall (PSW) that... 
SURGERY | ONCOLOGY | RECURRENT | EXCISION | EXENTERATION | CANCER | CARCINOMA | UTERINE
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 9, pp. 822 - 832
Journal Article
CANCERS, ISSN 2072-6694, 08/2019, Volume 11, Issue 8, p. 1169
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 10, pp. 943 - 949
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. 1558 - 1560
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 78 - 89
Summary Background Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor,... 
Hematology, Oncology and Palliative Medicine | BIBF 1120 | DES CANCERS | INTERGROUP TRIAL | LABEL DOSE-ESCALATION | CISPLATIN | ONCOLOGY | BEVACIZUMAB | TRIPLE ANGIOKINASE INHIBITOR | CARBOPLATIN PLUS PACLITAXEL | III TRIAL | MAINTENANCE THERAPY | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Diarrhea - chemically induced | Cytoreduction Surgical Procedures | Indoles - administration & dosage | Young Adult | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Double-Blind Method | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Anemia - chemically induced | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Thrombocytopenia - chemically induced | Disease Progression | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Intention to Treat Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | Clinical trials | Chemotherapy | Hospitals | Growth factors | Cancer | Ovarian cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article